BEAM

BEAM EBITDA Growth

83.22%TTM

Period ending:

BEAM TTM EBITDA YoY %%
BEAM TTM EBITDA YoY %142.13%-413.89%
2019-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

BEAM ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 27 observations from Dec 31, 2019 to Jun 30, 2026.

Beam Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
83.2225%
88.3189%
83.7369%
-226.2153%
-213.7018%
-224.4817%
-219.1914%
59.0783%
60.8792%
62.1526%
59.0658%
-104.1889%
-360.0819%
-309.1418%
-31.9572%
57.5657%
80.896%
75.7464%
-60.728%
-198.0688%
-267.9774%
-246.3939%
-78.6786%
-80.9941%
-73.0755%
-81.238%
-58.9031%

Compare ebitda growth

All BEAM financial metrics · BEAM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.